BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34235591)

  • 1. Protective effect of andrographolide against STZ induced Alzheimer's disease in experimental rats: possible neuromodulation and Aβ
    Patel R; Kaur K; Singh S
    Inflammopharmacology; 2021 Aug; 29(4):1157-1168. PubMed ID: 34235591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ
    Singh L; Singh S
    Neurosci Lett; 2023 Mar; 799():137090. PubMed ID: 36690059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide Attenuates Short-Term Spatial and Recognition Memory Impairment and Neuroinflammation Induced by a Streptozotocin Rat Model of Alzheimer's Disease.
    Souza LC; Andrade MK; Azevedo EM; Ramos DC; Bail EL; Vital MABF
    Neurotox Res; 2022 Oct; 40(5):1440-1454. PubMed ID: 36029454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats.
    Dhami M; Raj K; Singh S
    Curr Alzheimer Res; 2021; 18(8):623-637. PubMed ID: 34792011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance.
    Akhtar A; Dhaliwal J; Sah SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
    Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
    Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of 5-HT
    Afshar S; Shahidi S; Rohani AH; Soleimani Asl S; Komaki A
    J Chem Neuroanat; 2019 Mar; 96():140-147. PubMed ID: 30684605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacin B exerts neuroprotection in a murine Alzheimer's disease model by modulating oxidative stress, inflammation, and neurotransmitter levels.
    Liu Z; Kumar M; Kabra A
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):71. PubMed ID: 35227014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism.
    Kaundal M; Deshmukh R; Akhtar M
    Pharmacol Rep; 2018 Jun; 70(3):540-548. PubMed ID: 29674241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses.
    Chu S; Gu J; Feng L; Liu J; Zhang M; Jia X; Liu M; Yao D
    Int Immunopharmacol; 2014 Apr; 19(2):317-26. PubMed ID: 24503167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embelin Attenuates Intracerebroventricular Streptozotocin-Induced Behavioral, Biochemical, and Neurochemical Abnormalities in Rats.
    Arora R; Deshmukh R
    Mol Neurobiol; 2017 Nov; 54(9):6670-6680. PubMed ID: 27744573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Aβ and BACE-1.
    Zameer S; Kaundal M; Vohora D; Ali J; Kalam Najmi A; Akhtar M
    Neurotoxicology; 2019 Jan; 70():122-134. PubMed ID: 30481507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
    Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus.
    Zhang J; Zhen YF; Pu-Bu-Ci-Ren ; Song LG; Kong WN; Shao TM; Li X; Chai XQ
    Behav Brain Res; 2013 May; 244():70-81. PubMed ID: 23396166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.
    Sachdeva AK; Chopra K
    J Nutr Biochem; 2015 Jul; 26(7):736-44. PubMed ID: 25869595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats.
    Yang W; Ma J; Liu Z; Lu Y; Hu B; Yu H
    Neurol Sci; 2014 May; 35(5):741-51. PubMed ID: 24337945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
    Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
    Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats.
    Gomaa AA; Makboul RM; El-Mokhtar MA; Abdel-Rahman EA; Ahmed EA; Nicola MA
    Fundam Clin Pharmacol; 2021 Feb; 35(1):97-112. PubMed ID: 32602568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions.
    Teixeira FC; Gutierres JM; Soares MSP; da Siveira de Mattos B; Spohr L; do Couto CAT; Bona NP; Assmann CE; Morsch VM; da Cruz IBM; Stefanello FM; Spanevello RM
    Psychopharmacology (Berl); 2020 Mar; 237(3):811-823. PubMed ID: 31834453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.